The metabolic activation of ronidazole [(1-methyl-5-nitroimidazole-2-yl)-methyl carbamate] to reactive metabolites by mammalian, cecal bacterial and T. foetus enzymes
- 1 January 1986
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (1), 33-36
- https://doi.org/10.1016/0006-2952(86)90551-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Drug residue formation from ronidazole, a 5-nitroimidazole. VI. lack of mutagenic activity of reduced metabolites and derivatives of ronidazoleChemico-Biological Interactions, 1984
- Treatment of Trichomonas vaginalis InfectionsClinical Infectious Diseases, 1982
- Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitroChemico-Biological Interactions, 1982
- Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitroChemico-Biological Interactions, 1982
- Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylationChemico-Biological Interactions, 1982
- MetronidazoleMedical Clinics of North America, 1982
- The mutagenic action of nitroimidazoles: IV. A comparison of the mutagenic action of several nitroimidazoles and some imidazolesMutation Research/Genetic Toxicology, 1979
- Metronidazole in Anaerobic InfectionsDrugs, 1978
- The antibacterial activity of metronidazoleJournal of Antimicrobial Chemotherapy, 1975
- Mutagenicity of metronidazole: Activation by mammalian liver microsomesBiochemical and Biophysical Research Communications, 1975